Synthesis and Antifungal Activity of Pyrimidine Derivatives Containing an Amide Moiety.

In this study, 17 novel pyrimidine derivatives containing an amide moiety were synthesized. Then their in vitro antifungal activities against Botryosphaeria dothidea (B. dothidea), Phomopsis sp., and Botrytis cinereal (B. cinereal) were determined. A preliminary biological test showed that compounds 5-bromo-2-fluoro-N-(2-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)oxy)phenyl)benzamide (5f) and 5-bromo-2-fluoro-N-(3-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)oxy)phenyl)benzamide (5o) exhibited higher antifungal activity against Phomopsis sp., with an inhibition rate of 100% compared to that of Pyrimethanil at 85.1%. In particular, compound 5o exhibited excellent antifungal activity against Phompsis sp., with the EC50 value of 10.5 μg/ml, which was even better than that of Pyrimethanil (32.1 μg/ml). As far as we know, this is the first report on the antifungal activities against B. dothidea, Phomopsis sp., and B. cinereal of this series of pyrimidine derivatives containing an amide moiety.

Introduction

Plant fungal diseases pose serious threats to crop production and caused huge economic losses throughout the world (Strange and Scott, 2005). In recent years, crop cultivators continually battle with plant fungal diseases affecting crops. The available traditional fungicides used for plant fungal diseases control represent a danger to the living system by killing not only the target fungi but also affecting beneficial living systems (Patel et al., 2014). To protect crops from fungal diseases, commercial agriculture relies heavily on the inputs of chemical pesticides. The resistance of plant fungal diseases against fungicides is rapidly becoming a serious problem. Therefore, the development of novel and promising fungicides is urgently required.

Pyrimidines are important substances in the synthesis of various active molecules that are extensively used in the intermediate skeleton of agrochemicals (Chen et al., 2015; Wu et al., 2015) and have attracted more and more attention due to their extensive biological activities (Sun et al., 2006), including antiviral (Wu et al., 2016a), antibacterial (Wu et al., 2016b), antifungal (Wu et al., 2019, 2020), and insecticidal (Liu et al., 2017; Wu et al., 2020) activities. For example, Zan et al. reported pyrimidine derivatives bearing a dithioacetal moiety as effective antiviral agents for controlling the tomato chlorosis virus (ToCV) (Zan et al., 2021). Zhang et al. found a series of arylpyrazole pyrimidine ether derivatives with promising bioactivity for combating cucumber downy mildew (Zhang et al., 2019). Li and coworkers showed that pyrimidine thiourea derivatives had good herbicidal activities against Digitaria adscendens and Amaranthus retroflexus (Li et al., 2021a). In the past few years, several pyrimidine compounds have been commercialized as fungicides (such as Pyrimethanil, Fenarimol, Diflumetorim, and Mepanioyrim) for controlling plant fungal diseases, such as cucumber gray mold (Wang et al., 2021), grape downy mildew (Huang et al., 2018), kiwifruit leaf spot (Shi et al., 2021), and so on. Due to the excellent features of low toxicity, the fact that it is easily synthetized and derived, and considering pyrimidine as a parent compound, the development of promising agrochemical candidates will soon become a reality. Meanwhile, amine, a key moiety in heterocyclic chemistry, play a leading role in pesticide chemistry due to their potent bioactivities including antifungal (Cheng et al., 2020; Chen et al., 2021a), antibacterial (Chen et al., 2021a), antiviral (Tang et al., 2020), herbicidal (Sun et al., 2020), and insecticidal (Chen et al., 2021b; Li et al., 2021b) activities. In our previous work, we reported a series of novel pyrimidine derivatives containing an amine moiety (Figure 1) and found that the target compounds revealed certain antifungal, insecticidal, and antiviral activities (Wu et al., 2016a: Wu et al., 2020).

FIGURE 1

Structures of pyrimidine derivatives containing an amide moiety reported in our previous works.

This study aimed to design and synthesize a series of novel pyrimidine derivatives containing an amide moiety, and investigate their in vitro antifungal activities against Botryosphaeria dothidea (B. dothidea), Phomopsis sp., and Botrytis cinereal (B. cinereal). A biological test showed that compound 5-bromo-2-fluoro-N-(3-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)oxy)phenyl)benzamide (5o) exhibited excellent antifungal activity against Phompsis sp., with an EC50 value of 10.5 μg/ml, which is even better than Pyrimethanil (32.1 μg/ml).

Materials and Methods

General Information

The melting points of the products were determined on an XT-4 binocular microscope (Beijing Tech Instrument Co., China) and were not corrected. 1H and 13C NMR (solvent DMSO-d ) spectra were recorded on a Bruker AVANCE HD 600 MHz Digital NMR Spectrometer (Bruker Company, Billerica, MA, United States) at room temperature using TMS as an internal standard. High-resolution mass spectrometry (HRMS) was carried out on an Agilent Technologies 6540 UHD Accurate-Mass Q-TOF LC/MS (Agilent Technologies, Palo Alto, CA, United States). All anhydrous solvents were dried and purified according to standard techniques before use. Unless otherwise noted, all common reagents and solvents were used as obtained from commercial supplies without further purifications.

Synthesis

General Procedure for the Preparation of the Intermediates 2–4

As shown in Scheme 1, to a 250 ml round bottom flask, trifluoroacetoacetate (1, 0.05 mol), acetamidine hydrochloride (0.05 mol), sodium methoxide (0.075 mol), and ethanol (100 ml) were added and refluxed for 10 h. After that, the mixture was acidified with dilute HCl to pH 7. The crude products were extracted using ethyl acetate to produce intermediate 2. Then, intermediate 2 (0.05 mol), POCl3 (0.1 mol), and CH3CN (120 ml) were added to a 250 ml round bottom flask to react for 0.5 h at a reflux temperature and then diisopropylethylamine (0.06 mol) was added dropwise. After continuously refluxing for 8 h, excess POCl3 and CH3CN were distilled and then ice water (60 ml) was added. Finally, the mixture was alkalified with dilute NaOH to pH 9 and extracted using CH2Cl2 to give intermediate 3.

SCHEME 1

Synthetic routes of the target compounds 5a–5q.

To a 50 ml three-necked round-bottomed flask equipped with a magnetic stirrer, the key intermediate 3 (0.01 mol) was dissolved in acetone (50 ml), Cs2CO3 (0.012 mol), and 3-aminophenol or 2-aminophenol (0.01 mol) were added. The reactions reacted for 5–6 h at room temperature, and the solvent was removed. The residue was added with water, the precipitate formed was filtered off and recrystallized from ethanol to give the intermediate 4.

General Procedure for the Preparation of the Target Compounds 5a-5q

To a 50 ml three-necked round-bottomed flask equipped with a magnetic stirrer, the key intermediate 4 (0.02 mol), aromatic acid (0.02 mol), and dimethylaminopyridine (0.0002 mol) dissolved in dichloromethane (10 ml), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.03 mol) were added. The reactions were reacted for 8–10 h at room temperature. The solvent was then dried under vacuum and recrystallized from ethanol to give the pure target compounds 5a–5q.

The structures were confirmed by 1H NMR, 13C NMR, and HRMS. 1H NMR, 13C NMR, and HRMS spectral data for the target compounds 5a–5q are reported in the Supplementary Material. In the 1H NMR spectra of 5a–5q, one singlet at δ 9.70–10.74 ppm were attributed to the -CONH-. A singlet at δ 6.90–7.54 ppm demonstrated the presence of the proton of the pyrimidine fragment. A singlet at δ 2.31–2.54 ppm integrating for three protons was assigned to Pyrimidine-CH3 protons. The structure of 5a–5q was also confirmed by its HRMS spectral data. In all HRMS spectrum, the molecular ion peak was noticed m/z for ([M + H]+) corresponding to all of the target molecular weight.

(5a). White solid; yield 75%; m.p. 173–175°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 9.72 (s, 1H), 7.96 (d, 2H, J = 7.8 Hz), 7.76 (d, 1H, J = 7.2 Hz), 7.71 (t, 1H, J = 8.4 Hz), 7.53 (t, 2H, J = 9.0 Hz), 7.41–7.31 (m, 3H, Ph-H), 6.90 (s, 1H), 2.32 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 168.66, 164.39, 162.11, 152.99 (q, J = 33.6 Hz), 144.29, 134.43, 130.75, 130.08, 129.35, 129.22, 126.84, 126.40, 125.99, 124.06, 122.24 (q, J = 272.85 Hz), 100.17, 25.75; HRMS (calcd.) for C19H14F3N3O2 (M + H)+ 374.1107, found 374.1107.

2-Chloro- (5b). White solid; yield 49%; m.p. 157–158°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 9.73 (s, 1H), 7.93 (d, 1H, J = 7.8 Hz), 7.82 (d, 1H, J = 6.0 Hz), 7.66–7.63 (m, 2H), 7.49–7.46 (m, 1H), 7.43 (d, 1H, J = 7.8 Hz), 7.40–7.33 (m, 2H), 6.91 (s, 1H), 2.38 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 168.75, 162.96, 162.24, 153.25 (q, J = 33.6 Hz), 144.14, 134.62, 133.51, 132.34, 131.70, 130.75, 128.70, 127.80, 127.14, 126.60, 123.97, 122.28 (q, J = 272.55 Hz), 120.46, 100.24, 25.86; HRMS (calcd.) for C19H13ClF3N3O2 (M + H)+ 408.0721, found 408.0720.

(5c). White solid; yield 46%; m.p. 148–150°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 9.77 (s, 1H), 7.94 (t, 2H, J = 6.0 Hz), 7.86–7.81 (m, 3H), 7.41–7.36 (m, 3H), 6.92 (s, 1H), 2.39 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 168.75, 163.97, 162.25, 153.52 (q, J = 33.6 Hz), 144.03, 133.33, 133.21, 131.22, 130.77, 129.50, 128.33, 128.11 (q, J = 31.95 Hz), 127.52, 127.36, 126.57, 124.65 (q, J = 272.1 Hz), 123.45, 122.25 (q, J = 272.7 Hz), 120.45, 100.23, 25.85; HRMS (calcd.) for C20H13F6N3O2 (M + H)+ 442.0985, found 442.0979.

(5d). White solid; yield 68%; m.p. 138–140°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 9.81 (s, 1H), 8.30 (d, 1H, J = 7.8 Hz), 8.14 (s, 1H), 8.09 (d, 1H, J = 7.8 Hz), 7.82 (t, 1H, J = 7.8 Hz), 7.78 (d, 1H, J = 7.2 Hz), 7.48 (d, 1H, J = 8.4 Hz), 7.41–7.35 (m, 2H), 6.91 (s, 1H), 2.30 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 168.66, 163.13, 162.04, 153.33 (q, J = 34.2 Hz), 144.11, 134.06, 130.82, 130.77, 130.60, 130.55, 130.16 (q, J = 31.65 Hz), 127.09, 126.44, 126.08, 126.00, 124.92 (q, J = 270.9 Hz), 124.18, 123.10 (q, J = 270.6 Hz), 100.10, 25.60; HRMS (calcd.) for C20H13F6N3O2 (M + H)+ 442.0985, found 442.0979.

2,3-Dimethoxy (5e). White solid; yield 50%; m.p. 130–131°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 7.63 (s, 1H),7.54 (d, 1H, J = 7.6 Hz), 7.46 (t, 1H, J = 7.4 Hz), 7.41 (d, 1H, J = 8.1 Hz), 7.35–7.33 (m, 2H), 7.06 (d, 1H, J = 8.1 Hz), 6.97 (t, 1H, J = 7.9 Hz), 6.92 (d, 1H, J = 7.6 Hz), 3.76 (s, 3H), 3.69 (s, 3H), 2.40 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 169.52, 168.91, 162.84, 156.21 (q, J = 35.25 Hz), 152.54, 147.60, 145.80, 132.19, 131.54, 130.54, 127.24, 124.32, 124.10, 121.66 (q, J = 273.45 Hz), 115.48, 108.51, 103.05, 61.44, 56.28, 25.56; HRMS (calcd.) for C21H18F3N3O4 (M + H)+ 434.1322, found 434.1318.

3,4,5-trimethoxy (5g). White solid; yield 58%; m.p. 127–128°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 9.74 (s, 1H), 7.72 (d, 1H, J = 7.8 Hz), 7.40–7.35 (m, 3H),7.21 (s, 2H, Ph-H), 6.89 (s, 1H),3.78 (s, 6H), 3.75 (s, 3H) 2.33 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 168.77, 163.92, 153.21 (q, J = 34.6 Hz), 153.18, 142.77, 130.66, 126.93, 124.22, 120.40 (q, J = 272.3 Hz),107.36, 60.67, 56.37, 25.76; HRMS (calcd.) for C22H20F3N3O5 (M + H)+ 464.1428, found 464.1420.

2-Chloro- (5h). White solid; yield 62%; m.p.136–139°C; 1H NMR (DMSO-d , 600 MHz, ppm) δ: 10.74 (s, 1H), 7.75 (s, 1H), 7.62–7.58 (m, 3H), 7.54–7.52 (m, 2H), 7.49–7.45 (m, 2H), 7.04 (dd, 1H, J 1 = 1.3 Hz, J 2 = 8.0 Hz), 2.54 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.52, 169.76, 165.62, 156.54 (q, J = 34.65 Hz), 155.83, 152.36, 140.85, 137.16, 131.74, 130.56, 130.40, 130.18, 129.43, 127.78, 123.67 (q, J = 273.45 Hz), 117.52, 117.46, 112.91, 103.46, 25.94; HRMS (calcd.) for C19H13ClF3N3O2 (M + H)+ 408.0721, found 408.0716.

4-Fluoro (5i). White solid; yield 85%; m.p. 136–139°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 9.72 (s, 1H), 8.06–8.04 (dd, 2H, J 1 = 5.4 Hz, J 2 = 8.4 Hz), 7.79 (d, 1H, J = 7.2 Hz), 7.41–7.35 (m, 5H), 7.31 (t, 1H, J = 7.8 Hz), 6.91 (s, 1H), 2.37 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 168.67, 167.65, 165.07, 163.46, 162.07, 153.20 (q, J = 33.75 Hz), 144.08, 133.11, 130.74, 126.87, 126.30, 125.99, 125.89, 124.18, 122.23 (q, J = 272.85 Hz), 116.48, 100.25, 25.75; HRMS (calcd.) for C19H13F4N3O2 (M + H)+ 392.1017, found 392.1013.

(5j). White solid; yield 73%; m.p. 140–142°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.80 (s, 1H), 7.87 (d, 1H, J = 7.7 Hz), 7.82 (t, 1H, J = 7.3 Hz), 7.75–7.72 (m, 3H), 7.58 (d, 1H, J = 7.9 Hz), 7.52 (s, 1H), 7.47 (t, 1H, J = 8.2 Hz), 7.05 (d, 1H, J = 7.7 Hz), 2.54 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.48, 169.75, 166.26, 156.33 (q, J = 33.6 Hz), 152.36, 140.81, 136.36, 133.14, 130.55, 129.02, 126.84, 126.46 (q, J = 31.05 Hz), 123.32 (q, J = 271.8 Hz), 121.84 (q, J = 272.85 Hz), 117.50, 112.97, 103.46, 25.91; HRMS (calcd.) for C20H13F6N3O2 (M + H)+ 442.0985, found 442.0982.

(5k). White solid; yield 73%; m.p. 101–103°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.65 (s, 1H), 8.30 (s, 1H), 8.27 (d, 1H, J = 7.8 Hz), 7.97 (d, 1H, J = 7.7 Hz), 7.81–7.79 (m, 2H), 7.71 (d, 1H, J = 8.1 Hz), 7.50 (s, 1H), 7.48 (d, 1H, J = 8.2 Hz), 7.05 (d, 1H, J = 8.0 Hz), 2.53 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.56, 169.79, 164.71, 156.34 (q, J = 33.6 Hz), 152.29, 140.81, 136.01, 132.35, 130.22, 130.02, 129.81 (q, J = 31.8 Hz), 128.74, 125.31 (q, J = 271.8 Hz), 124.75, 123.52, 121.82 (q, J = 273.0 Hz), 118.39, 117.52, 113.84, 103.36, 25.91; HRMS (calcd.) for C20H13F6N3O2 (M + H)+ 442.0985, found 442.0983.

(5l). White solid; yield 80%; m.p. 94–96°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.66 (s, 1H), 8.15 (d, 2H, J = 8.4 Hz), 7.94 (d, 2H, J = 7.8 Hz), 7.79 (t, 1H, J = 1.8 Hz), 7.69 (d, 1H, J = 9.6 Hz), 7.52 (s, 1H), 7.49 (t, 1H, J = 8.4 Hz), 7.06 (d, 2H, J = 7.8 Hz), 2.53 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.59, 169.80, 165.13, 156.34 (q, J = 34.6 Hz), 152.31, 140.83, 138.99, 132.11 (q, J = 31.62 Hz),130.52, 129.16, 125.98, 125.31(q, J = 273.25 Hz), 120.05 (q, J = 272.51 Hz), 118.35, 117.61 103.48, 25.98; HRMS (calcd.) for C20H13F6N3O2 (M + H)+ 442.0985, found 442.0978.

2,3-Dimethoxy (5m). White solid; yield 52%; m.p. 108–109°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10. 47 (s, 1H), 7.78 (s, 1H), 7.62 (d, 1H, J = 7.9 Hz), 7.51 (s, 1H), 7.45 (t, 1H, J = 8.2 Hz), 7.22–7.17 (m, 2H), 7.13 (dd, 1H, J = 1.4 Hz, J = 7.3 Hz), 7.02 (dd, 1H, J = 1.3 Hz, J = 8.0 Hz), 3.87 (s, 3H), 3.82 (s, 3H), 2.54 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.55, 169.79, 165.59, 156.31 (q, J = 34.8 Hz), 153.05, 152.35, 146.32, 141.05, 131.70, 130.46, 124.72, 121.85 (q, J = 273.45 Hz), 120.45, 117.54, 117.10, 115.23, 112.91, 103.40, 61.57, 56.42, 25.92; HRMS (calcd.) for C21H18F3N3O4 (M + H)+ 434.1322, found 434.1318.

3-Bromo-4-chloro- (5n). White solid; yield 68%; m.p. 143–145°C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.56 (s, 1H), 8.35 (d, 1H, J = 1.9 Hz), 7.97 (dd, 1H, J = 2.1 Hz, J = 8.3 Hz), 7.80 (d, 1H, J = 8.4 Hz), 7.76 (s, 1H), 7.68 (d, 1H, J = 8.1 Hz), 7.54–7.52 (m, 2H, Ph-H), 7.49–7.46 (m, 2H), 7.04 (dd, 1H, J = 1.4 Hz, J = 8.0 Hz), 2.53 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.54, 169.79, 163.71, 156.33 (q, J = 34.8 Hz), 152.27, 140.74, 137.07, 135.34, 133.25, 131.05, 130.42, 129.12, 122.11, 121.81 (q, J = 273.3 Hz), 118.31, 117.51, 113.76, 103.37, 25.92; HRMS (calcd.) for C19H12BrClF3N3O2 (M + H)+ 485.9826, found 485.9822.

5-Bromo-2-fluoro- (5o). White solid; yield 52%; m.p.147–149 °C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.74 (s, 1H), 7.89–7.87 (m, 1H), 7.79–7.77 (m, 1H, Ph-H), 7.73 (s, 1H), 7.60 (d, 1H, J = 7.9 Hz), 7.50 (s, 1H), 7.47 (t, 1H, J = 8.2 Hz), 7.38 (t, 1H, J = 9.3 Hz), 7.05 (dd, 1H, J 1 = 1.4 Hz, J 2 = 8.0 Hz), 2.53 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.52, 169.76, 161.91, 159.46, 157.80, 156.32 (q, J = 34.65 Hz), 152.34, 140.55, 135.67, 132.64, 130.58, 127.15, 121.83 (q, J = 273.15 Hz), 119.24, 117.66, 116.63, 113.19, 103.42, 25.92; HRMS(calcd.) for C19H12BrF4N3O2 (M + H)+ 470.0122, found 470.0117.

2-Bromo-5-fluoro- (5p). White solid; yield 60%; m.p.152–153 °C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.78 (s, 1H), 7.78 (q, 1H, J = 5.0 Hz), 7.72 (s, 1H), 7.59–7.58 (m, 2H), 7.52 (s, 1H), 7.48 (t, 1H, J = 8.2 Hz), 7.34 (dd, 1H, J 1 = 3.0 Hz, J 2 = 8.6 Hz, Ph-H), 7.06 (dd, 1H, J 1 = 1.4 Hz, J 2 = 8.0 Hz), 2.54 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.49, 169.75, 165.15, 162.38, 160.74, 156.31 (q, J = 34.65 Hz), 152.36, 140.82, 140.64, 135.16, 130.60, 121.84 (q, J = 273.15 Hz), 118.87, 117.59, 116.63, 114.21, 112.98, 103.49, 25.94; HRMS(calcd.) for C19H12BrF4N3O2 (M + H)+ 470.0122, found 470.0118.

3,4,5-trimethoxy- (5q). White solid; yield 78%; m.p.116–117 °C; 1H NMR (DMSO-d 6, 600 MHz, ppm) δ: 10.31 (s, 1H), 7.73 (s, 1H), 7.69 (d, 1H, J = 7.8 Hz), 7.51 (s, 1H), 7.48 (t, 1H, J = 7.8 Hz), 7.28 (s, 2H), 7.03 (d, 1H, J = 7.8 Hz), 3.87 (s, 3H), 3.74 (s, 3H), 2.51 (s, 3H); 13C NMR (DMSO-d 6, 150 MHz, ppm) δ: 170.59, 169.79, 165.58, 156.31 (q, J = 34.65 Hz), 153.11, 152.27, 141.07, 140.90, 130.37, 130.23, 120.02 (q, J = 272.85 Hz), 118.41, 117.19, 113.82, 105.78, 103.35, 60.58, 56.55, 25.92; HRMS(calcd.) for C22H20F3N3O2 (M + H)+ 464.1428, found 464.1425.

In Vitro Antifungal Activity Test

The antifungal activities of all synthesized compounds at the concentration of 50 μg/ml were evaluated for their in vitro antifungal activities against the pathogenic fungi, including B. dothidea, Phompsis sp., and B. cinerea by the poison plate technique (Min et al., 2016). All the compounds were dissolved in 1 ml dimethyl sulfoxide (DMSO) before mixing with 90 ml potato dextrose agar (PDA). Mycelia dishes of approximately 5 mm diameter were cut from the culture medium and then picked up with a germfree inoculation needle and inoculated in the middle of the PDA plate aseptically. The inoculated plates were fostered at 27 ± 1 C for 3–4 days. DMSO in sterile distilled water served as a negative control, while Pyrimethanil acted as a positive control. For each treatment, three replicates were conducted. The inhibition rate I (%) was calculated by the following formula, where C (cm) represents the diameter of fungi growth on untreated PDA, and T (cm) represents the diameter of fungi on treated PDA.

Results and Discussion

Antifungal Activity Test in vitro

The in vitro antifungal activities of the title compounds against the pathogenic fungi, including B. dothidea, Phomopsis sp., and B. cinereal at 50 μg/ml were tested and the results are shown in Table 1. Bioassay results showed that compounds 5i, 5l, 5n, and 5o had good inhibition rates on B. dothidea, with the inhibition rates of 82.1, 81.1, 84.1, and 88.5%, respectively, which were similar to Pyrimethanil (84.4%). Meanwhile, the inhibition rates of compounds 5f, 5n, 5o, and 5p against Phomopsis sp. were 100.0, 91.8, 100.0, and 93.4%, which were even better than Pyrimethanil (85.1%). In addition, some of the target compounds, for example compounds 5c (80.0%), 5i (79.6%), 5l (80.4%), 5m (83.6%), 5n (79.7%), 5o (84.7%), and 5q (80.5%), showed equally antifungal activity against B. cinerea to Pyrimethanil (82.8%).

TABLE 1

| The antifungal activities of the title compounds against B. dothidea, Phomopsis sp., and B. cinereal at 50 μg/ml.

Compounds	Inhibition rate (%)
	B. dothidea	Phomopsis sp	B. cinerea
5a	75.6 ± 2.1	73.6 ± 2.2	60.3 ± 1.8
5b	76.2 ± 1.3	81.0 ± 1.3	73.1 ± 1.3
5c	62.5 ± 1.1	75.5 ± 1.8	80.0 ± 2.5
5d	70.5 ± 1.6	80.2 ± 2.2	70.6 ± 1.2
5e	54.6 ± 1.5	76.0 ± 1.4	73.3 ± 1.9
5f	72.3 ± 1.9	100.0 ± 2.1	59.7 ± 2.4
5g	46.8 ± 1.0	60.1 ± 2.0	73.8 ± 2.0
5h	78.5 ± 2.6	86.1 ± 1.9	75.8 ± 2.6
5i	82.1 ± 3.0	84.4 ± 2.1	79.6 ± 1.4
5g	72.4 ± 1.9	78.0 ± 2.2	72.1 ± 3.2
5k	76.9 ± 1.0	81.2 ± 1.8	77.5 ± 1.8
5l	81.1 ± 1.2	84.5 ± 1.7	80.4 ± 1.2
5m	48.9 ± 1.7	57.8 ± 1.3	83.6 ± 1.2
5n	84.1 ± 2.3	91.8 ± 1.4	79.7 ± 2.4
5o	88.5 ± 3.3	100.0 ± 1.0	84.7 ± 2.6
5p	79.9 ± 1.8	93.4 ± 1.5	75.2 ± 1.2
5q	54.5 ± 1.6	62.1 ± 1.4	80.5 ± 0.9
Pyrimethanil	84.4 ± 2.1	85.1 ± 1.4	82.8 ± 1.4

The EC50 values and antifungal diagram of the target compounds 5f, 5o, and 5p were also tested and are presented in Table 2 and Figure 2 respectively. Table 2 shows that compounds 5f, 5o, and 5p exhibited excellent antifungal activity against Phomopsis sp., with the EC50 values of 15.1, 10.5, and 19.6 μg/ml, which were superior to that of Pyrimethanil (32.1 μg/ml).

TABLE 2

| The EC50 values of the target compounds against Phompsis sp.

Compounds	Toxic regression equation	r	EC50 (μg/mL)
5f	y = 2.42x + 3.62	0.99	15.1 ± 2.0
5o	y = 2.38x + 4.20	0.99	10.5 ± 1.4
5p	y = 3.45x + 2.65	0.99	19.6 ± 2.5
Pyrimethanil	y = 2.18x + 8.25	0.99	32.1 ± 2.0

FIGURE 2

EC50 values of the target compounds 5f, 5o, and 5p against Phomopsis sp.

Structure-Function Relationship Analysis

In order to design novel and more promising active small molecules of pyrimidine derivatives, SAR analysis was also performed. The chemical structure of the target compounds indicated that the position of the amine group and the position and size of the substituent group R of the target compounds significantly influence the antifungal activities against. B. dothidea, Phomopsis sp. and B. cinereal. With the amine group at 3-position of the benzene ring and F and Br atoms at 2- and 5-position, respectively, compound 5o exhibited excellent antifungal activities against. B. dothidea, Phomopsis sp. and B. cinereal, which were even better than those of Pyrimethanil. Meanwhile, in general terms, the antifungal activities of the target compounds with the amine group at 3-position of benzene ring were better than those of the corresponding target compounds with the amine group at 2-position of the benzene ring, for example, 5h > 5b and 5k > 5d.

Conclusion

In conclusion, a total of 17 pyrimidine derivatives containing an amide moiety were synthesized and evaluated for their in vitro fungicidal activities against B. dothidea, Phompsis sp., and B. cinerea by the poison plate technique. Bioassay results demonstrated that compound 5-bromo-2-fluoro-N-(3-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)oxy)phenyl)benzamide (5o) exhibited excellent antifungal activity against Phompsis sp., with the EC50 value of 10.5 μg/ml, which were even better than that of Pyrimethanil. This study provided a practical tool for guiding the design and synthesis of novel and more promising active small molecules of pyrimidine derivatives for controlling Phompsis sp., This study also demonstrated that this series of pyrimidine derivatives containing an amide moiety can be used to develop potential agrochemicals. In accordance with the pesticide registration requirements in China, further field and toxicity studies of compound 5o will be undertaken in a future study.